HEPARIN sodium, 5 000 IU/ml, 5ml, amp.
STD
DINJHEPA2A-
Valid Article
Account code:
60000
HS Code:
300490
Last Updated on:
31/07/2024, 22:00:23
10.2 - Medicines affecting coagulation
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
B01AB01
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
The product is part of at least one Kit.
A kit is a collection of products (medical and/or logistic) that are needed for a certain intervention in emergency. The choice and quantity of the articles reflects the MSF protocols for this specific situation. The use of Kits allows to start an intervention without a detailed evaluation.
HEPARIN sodium
Therapeutic Action
Anticoagulant
Indications
Venous and arterial thrombosis (pulmonary embolism, myocardial infarction, thrombophlebitis)
Prevention of venous and arterial thrombosis, especially in pre- and post-operative period and in patients on bedrest
Instructions for use
Administer by continuous IV infusion in 5% dextrose or 0.9% NaCl or
by intermittent IV injection, or by SC injection.
Closely monitor coagulation parameters and platelet.
Effects may be reversed by administration of protamine (specific heparin antagonist).
Benzyl alcohol-free formulation, preferred for paediatric use.
The ampoule presentation replaces the vial to provide benzyl alcohol-free heparin.
Precautions for Use
- Avoid combination with aspirin, non-steroidal anti-inflammatory drugs (increased risk of haemorrhage).
- Contra-indicated at the end of pregnancy (risk of haemorrhage during delivery).
Storage
Below 25°C - Protect from sunlight